Anti-Angiogenesis Maintenance Therapy in Newly Diagnosed and Relapsed Ovarian Cancer: A Meta-analysis of Phase III Randomized Controlled Trials

Aim: Anti-angiogenesis agents have been added as maintenance therapy in ovarian cancer over the past decade. The aim of this meta-analysis was to analyze the efficacy of anti-angiogenesis therapy in newly diagnosed and relapsed ovarian cancer. Methods: PubMed, Embase, and Cochrane databases were sea...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yizi, Zhang, Shitai, Song, Zixuan, Ouyang, Ling, Li, Yan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8636101/
https://www.ncbi.nlm.nih.gov/pubmed/34867330
http://dx.doi.org/10.3389/fphar.2021.726278

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8636101/
https://www.ncbi.nlm.nih.gov/pubmed/34867330
http://dx.doi.org/10.3389/fphar.2021.726278

Ejemplares similares